mynth
03/2019100%

Groupe Théma acquired by Theradial

FRANCE Software / Industry-Specific Software / Healthcare REV €5–25M

Context

This growth transaction marks a significant evolution for Théradial, transitioning from a specialized medical device distributor to a provider of an integrated ecosystem encompassing care equipment and clinical operation digital solutions. The acquisition of Groupe Théma is financed through a hybrid structure combining cash contribution and share exchange for the selling founders, as well as an extension of senior debt lines granted by the acquirer's historical banking pool. The underlying financial analysis is based on creating a significant competitive advantage by integrating medical consumables logistics flows into dialysis center management software interfaces, which will increase switching costs for hospital clients. In parallel, this domestic value chain rationalization is complemented by the integration of the target's Italian subsidiary, offering an immediate opportunity for international expansion of medical equipment sales in the European market, characterized by comparable reimbursement dynamics. The new governance structure preserves IT expertise by integrating Théma's founders into the executive committee, chaired by Frédéric Le Pottier, with the objective of deploying cross-selling synergies, aiming to reach a consolidated revenue of 35 million euros, while strengthening the healthcare establishment supply infrastructure, with an expanded presence in five new countries, entering new markets and broadening its customer base.

Groupe Théma, which reported an EBITDA margin of [members only] in 2019, is valued in this transaction at an EV/EBITDA multiple of [members only].

-> Deep-dive in TMT (Tech, Media, Telecom) market trends

Target

Groupe Théma operates as a specialized clinical IT vendor that designs and deploys proprietary workflow management software for hemodialysis centers and end-stage renal disease patient pathways. Operating under the Ema and Sined brands in France alongside a dedicated Sined subsidiary in Italy, the company monetizes its specialized codebase by embedding its digital solutions deeply into the daily operational architecture of institutional healthcare providers and independent dialysis clinics. The business generates highly sticky, recurring revenue streams derived from enterprise software licenses, ongoing clinical maintenance contracts, and system integration mandates tied to mission-critical hospital IT infrastructure upgrades. Customers, primarily clinical directors and hospital procurement boards, mandate these digital platforms to automate complex treatment scheduling, ensure strict regulatory traceability of consumable medical devices, and manage remote telemetry protocols for home dialysis patients.

Ent. Value

[members only]

Equity Value

[members only]

Multiples

EV / Revenue

[members only]

EV / EBITDA

[members only]

EV / EBIT

[members only]

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2019
€5–25M
[members only]
[members only]
2018
€5–25M
[members only]
[members only]

Other operations with Theradial

Other operations with Theradial
DateAcquirerTargetCountrySector
02/2023ARDIANTHERADIALFRANCEMedical Devices
10/2017UI INVESTISSEMENT / BPIFRANCETHERADIALFRANCEMedical Devices

Similar deals in Software

Similar deals in Software
DateAcquirerTargetCountrySector
05/2019BLACKROCKEFRONTFRANCEFinancial Services / Banking
05/2019BRIDGESTONE CORPORATIONTOMTOM TELEMATICSNETHERLANDSData, Analytics & AI
02/2019ASTORGANAQUAUNITED STATESIndustry-Specific Software
12/2018FIVE ARROWSHARVESTFRANCEFinancial Services / Banking
11/2018IK PARTNERSQUANOSGERMANYIndustry-Specific Software
11/2018BMAXMAXIFIERNORWAYAdTech
10/2018ABRY PARTNERSLINK MOBILITYNORWAYMarTech
10/2018SABA SOFTWARELUMESSE EX STEPSTONE SOLUTIONSGERMANYERP, HR & Finance
10/2018THOMA BRAVOVERACODEUNITED STATESSoftware
09/2018INSIGHT VENTURE PARTNERSOPTIMIZELY (EX EPISERVER)UNITED STATESMarTech

REFERENCES

Revenue range: REV €5–25M

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Groupe Théma by Theradial are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

FAQ

What transaction does this page cover?

This page covers Theradial’s acquisition of 100% of Groupe Théma, a French company specialised in Industry-Specific Software, in 2019.

What was Groupe Théma’s revenue at the time of the deal?

At the time of the transaction, Groupe Théma’s annual revenue was estimated within the €5–25M range (FY 2019). Detailed financial figures are available to members.

What sources support the information on this transaction?

Transaction data and operational intelligence were compiled from independent financial press reporting by specialized M&A publications.

What is mynth?

mynth is the first free M&A database dedicated to Small & Mid-Cap transactions. We centralize Enterprise Values, revenue multiples, EBITDA multiples and transaction financials that are typically locked behind five-figure subscriptions on platforms like Capital IQ or Mergermarket. On mynth, searching and browsing deals is completely free. Our mission is simple: make professional-grade valuation intelligence accessible to every M&A advisor, independent consultant, Private Equity professional and student, without the burden of expensive annual licenses.